gracecastuc 119 lung_dr. wakelee on targeted therapies generalizable to wider range of lung cancers
Published 11 years ago • 6 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:15
gracecastuc-054_lung_wakelee: my approach to repeat biopsies for adv. nsclc with insufficient tissue
-
2:07
gracecastuc109_lung_dr. wakelee on maintenance therapy advanced nsclc
-
1:50
gracecastuc-065_lung_dr. wakelee on most promising new agents and pathways for treating lung cancer
-
1:12
gracecastuc-053_lung_will gains in targeted therapies be generalizable to a wider range of lc?
-
4:37
targeted therapy in lung cancer: the importance of biomarkers - lcvl 2024
-
1:27
dr. heather wakelee on "which molecular marker tests do you seek?"
-
17:16
gracecast-028_lung-cancer_heather wakelee on nsclc adjuvant therapy
-
17:36
gracecast-096_lung-cancer_mm in lc pt 1: dr. charles rudin on the lung cancer mutation consortium
-
5:11
gracecastuc-015_lung_what is the biology of a mixed response in lung cancer?
-
13:44
gracecast-079_lung-cancer_challenging cases in lung cancer: unresectable locally advanced nsclc
-
1:59
gracecastuc-026_lung_dr. wakelee on using molecular marker info for mgmt. of earlier stage nsclc
-
1:59
gracecastuc-052_lung_juergens on managing acquired resistance to targeted therapies for adv. nsclc
-
0:40
how oncologists stage disease - #shorts
-
5:24
gracecast - lcvl - can immunotherapy help frail patients with advanced nsclc
-
2:01
gracecastuc114_lung_dr. spigel on targeted therapy toxicity vs chemotherapy
-
2:44
gracecastuc087_lung_dr. kelly on targeted therapy
-
4:51
targeted therapy side effects - lcvl 2024
-
11:35
gracecast151_lung_dr. kratz on prognosis of early lung cancer - part 2
-
3:51
gracecastuc-024_lung_dr. david spigel on promising future targeted therapy approaches in lung cancer